Skip to content
logo-grupo-sur
  • Home
  • About us
  • Research
  • Education
  • Scientific Publications
  • News
  • Contact
Menu
  • Home
  • About us
  • Research
  • Education
  • Scientific Publications
  • News
  • Contact

Category: Vaccines

The ANMAT approved the use of the first COVID-19 vaccine developed entirely in Argentina.

This is the ARVAC-Cecilia Grierson vaccine and it will be used as a booster against the COVID-19 variants circulating in the region. ✅ This vaccine, developed by the University of San Martín, scientific personnel from CONICET, and the Cassará laboratory, has proven to be safe and effective as a booster against COVID-19 in individuals over […]

Instagram Facebook Linkedin
  • Avenida 51 Numero 315 - C.P. B1900AVG - La Plata, Provincia de Buenos Aires |
  • 221 3144563
  • info@gruposur.ar |
  • Recursos Humanos: rrhh@gruposur.ar |
  • Sponsor / CRO: factibilidad@gruposur.ar

Grupo Sur Investigación Clínica
® Todos los derechos reservados 2021-2025

Sitio web y comunicación desarrollada por 

Logo Soon Branding (1)